292 related articles for article (PubMed ID: 31432447)
1. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis.
Liu B; Li Y; Li Y; Liu Y; Yan Y; Luo A; Ren H; She Q
Hepatol Int; 2019 Nov; 13(6):757-765. PubMed ID: 31432447
[TBL] [Abstract][Full Text] [Related]
2. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
[TBL] [Abstract][Full Text] [Related]
3. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
[TBL] [Abstract][Full Text] [Related]
4. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study.
Kim BJ; Cheong ES; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(3):619-626.e1. PubMed ID: 27206950
[TBL] [Abstract][Full Text] [Related]
5. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.
Sunbul M; Agirbasli M; Durmus E; Kivrak T; Akin H; Aydin Y; Ergelen R; Yilmaz Y
Atherosclerosis; 2014 Dec; 237(2):490-3. PubMed ID: 25463079
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study.
Lin A; Wong ND; Razipour A; McElhinney PA; Commandeur F; Cadet SJ; Gransar H; Chen X; Cantu S; Miller RJH; Nerlekar N; Wong DTL; Slomka PJ; Rozanski A; Tamarappoo BK; Berman DS; Dey D
Cardiovasc Diabetol; 2021 Jan; 20(1):27. PubMed ID: 33514365
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Non-Alcoholic Fatty Liver Disease and Electromechanical Reconstruction of Myocardium.
Tretyakova VA; Zhernakova NI; Arisheva OS; Garmash IV; Tretyakov A; Gerasimov NI; Ermilov OV
Arch Razi Inst; 2022 Feb; 77(1):135-140. PubMed ID: 35891721
[TBL] [Abstract][Full Text] [Related]
8. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
[TBL] [Abstract][Full Text] [Related]
9. Epicardial Fat in Nonalcoholic Fatty Liver Disease: Properties and Relationships With Metabolic Factors, Cardiac Structure, and Cardiac Function.
Psychari SN; Rekleiti N; Papaioannou N; Varhalama E; Drakoulis C; Apostolou TS; Iliodromitis EK
Angiology; 2016 Jan; 67(1):41-8. PubMed ID: 25818101
[TBL] [Abstract][Full Text] [Related]
10. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
11. The association between epicardial adipose tissue and non-alcoholic fatty liver disease: A systematic review of existing human studies.
Emamat H; Tangestani H; Behrad Nasab M; Ghalandari H; Hekmatdoost A
EXCLI J; 2021; 20():1096-1105. PubMed ID: 34345229
[TBL] [Abstract][Full Text] [Related]
12. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
[TBL] [Abstract][Full Text] [Related]
13. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.
Yilmaz Y; Kurt R; Gurdal A; Alahdab YO; Yonal O; Senates E; Polat N; Eren F; Imeryuz N; Oflaz H
Atherosclerosis; 2011 Jul; 217(1):125-9. PubMed ID: 21513939
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
[TBL] [Abstract][Full Text] [Related]
15. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
16. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD.
Perdomo CM; Ezponda A; Núñez-Córdoba JM; Herrero JI; Bastarrika G; Frühbeck G; Escalada J
Sci Rep; 2022 Apr; 12(1):6564. PubMed ID: 35449229
[TBL] [Abstract][Full Text] [Related]
17. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
18. Epicardial adipose tissue in patients with chronic kidney disease: a meta-analysis study and trial sequential analysis.
Song G; Qiao W; Liu K; Yu X
Int Urol Nephrol; 2020 Dec; 52(12):2345-2355. PubMed ID: 32720030
[TBL] [Abstract][Full Text] [Related]
19. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.
Iacobellis G; Barbarini G; Letizia C; Barbaro G
Obesity (Silver Spring); 2014 Feb; 22(2):332-6. PubMed ID: 24115757
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
Cho KI; Jo EA; Cho SH; Kim BH
Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
